HNFoundation
The Hereditary Neuropathy Foundation (HNF) mission is to increase awareness and accurate diagnosis of Charcot- Marie-Tooth (CMT) and related inherited neuropathies, support patients and families with critical information to improve quality of life, and fund research that will lead to treatments and cures. HNF was incorporated in 2001 and is a non-profit 501(c) 3.
In 2007, HNF developed the Therapeutic Research in Accelerated Discovery (TRIAD) program, a collaborative effort with academia, government and industry, to develop treatments for CMT. Currently TRIAD involves many groups that span the drug discovery, drug development, and diagnostics continuum.
For more information: www.hnf-cure.org
Join the Global Patient Registry for Inherited Neuropathies (GRIN): www.neuropathyreg.org
Join the CMT Inspire Community: https://www.inspire.com/groups/charcot-marie-tooth-cmt/
Thomas Holm Pederson, NMD Pharma - CMT Summit Keynote 2025
Patient Voices: Natalia Salejko - CMT Summit Nashville 2025
James Scramble 2025
Patient Voices: Alana Kohler - CMT Summit Nashville 2025
Patient Voices: Lindsey Flynt - CMT Summit Nashville 2025
Patient Voices: Reagan Warren - CMT Summit Nashville 2025
Lindsey Flynt: Mom of Jaxson MTRFR/C12orf65
🎥 HNF Webinar Replay: What NMD670 Means for Patients with CMT
Organileaf 🌿 CBD & CMT Symptoms:
Highlights of HNF's CMT Clinical Trial Readiness Summit, San Diego, June 7-8th 2024
CMT & Cannabis with Angie Roullier
Step 4: The Road Map to CMT Clinical Trials
Step 2: The Road Map to CMT Clinical Trials
Meet Zach & Jaxson living with C12orf65/MTRFR
Movement is Medicine™ 2019 Summit
Balance and Gait Study
CMT Highlight Reel: How does CMT data drive research using GRIN?
GRIN Demo: 7-Min Tour
Making Sense & Science of CMT Symptoms
The Key Role CMT Patients Play in Research
CMT THRIVE Summit Webinar - Caring for Caregivers
Wheel The World - CMT THRIVE Summit
Adaptive Driving for CMT
Empowering Kids with CMT
Dating + Love + CMT
Accessible CMT Home Tour